Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Cholinergic interneuron regulation of opioid-related behaviors

Award Number: R15DA058910
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/15/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2027

Group Awards By:

View Award Description

Cholinergic interneuron regulation of opioid-related behaviors - Project Summary Opioid use disorder (OUD) is a debilitating and life-long addictive disease with significant public health costs. OUD is characterized by various symptoms, including a compulsive need to use, loss of control over use, and a negative emotional state induced by withdrawal. Mu-opioid receptors (MORs) in the ventral tegmental area (VTA) are known to contribute to both the rewarding effects of opioid use and the aversive signs and symptoms of opioid withdrawal. However, there is growing evidence that additional populations of MOR, which is broadly expressed throughout emotional and motivational brain circuits, critically contribute to opioid-related behaviors. Striatal cholinergic interneurons (CINs) regulate dopamine release and responding for rewards. Given these important functions of CINs, and because this neuronal subpopulation expresses MOR, we hypothesize that MOR stimulation alters CIN activity and striatal dopamine release to promote opioid reward, consumption, and withdrawal-induced aversion. Our experiments will test this hypothesis through completion of two primary specific aims. We will determine 1) whether MORs on cholinergic interneurons participate in opioid reward and withdrawal and 2) whether CIN MORs regulate dopamine release during opioid reward and withdrawal. Opioid reward will be tested using a conditioned place preference (CPP) task and withdrawal using conditioned place aversion (CPA). Opioid consumption will be assessed with a limited access, two-bottle choice fentanyl drinking task developed in our lab. Collectively, completion of these aims will demonstrate that MORs on NAc CINs contribute to opioid reward, consumption, and withdrawal through modulation of DA release. Furthermore, we will train undergraduate students in a broad array of modern behavioral neuroscience techniques, such as chemogenetics, fluorescent in situ hybridization, and fluorophotometry. These activities will expand access to meaningful research opportunities to a diverse set of talented undergraduate students interested in neuroscience and other biomedical research fields at Miami University.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $373,181 )
2024	2024	MIAMI UNIVERSITY	501 E HIGH ST	OXFORD	OH	45056	BUTLER	USA	Drug Use and Addiction Research Programs	000	1	7/8/2024	NEW	$373,181
														Subtotal = $373,181

Grand Total All Awards = $373,181

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cholinergic interneuron regulation of opioid-related behaviors

Award Number: R15DA058910

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/15/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer